← Leaderboards
Lewis Zhichang Shi
University Of Alabama At Birmingham
$1,571,874
Attributed
$1,571,874
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $419.5K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,571,874 · 3
By mechanism
R01$838,922 · 1
R21$732,952 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Jianmei Wu Leavenworth$3,731,030
- Kyle D Wood$1,183,072
- Sonia Fargue$2,347,537
- Amy Susan Weinmann$10,617,595
- John C Chatham$14,297,780
Others in their field
Other Emerging Leaders on “Melanoma”
- Dawn C Ward · University Of California Los Angeles$7,282,377
- Kathleen Nicol · Research Inst Nationwide Children'S Hosp$7,187,946
- Tina Garyantes · Linnaeus Therapeutics, Llc$6,999,960
- Benjamin Izar · Dana-Farber Cancer Inst$6,774,069
- David M. Ashley · Duke University$6,274,552
- Zachary Scott Morris · University Of Wisconsin-Madison$5,820,528
Research focus
MelanomaInterferonsTherapy ResistantT-LymphocyteMetabolicMediatingPathway InteractionsNeoplastic CellSignal TransductionTumorResistanceDesignAnti-Ctla4Immune CheckpointImmune Checkpoint BlockadeImmunotherapyGeneticGlycolysisImmune Checkpoint BlockersInhibitorEnzymesCancer TypeGenesEragrostis
Grant awards (6)
T cell-intrinsic metabolic control of radiotherapy$419,461
R01 · FY2025 · CA · contact PI
T cell-intrinsic metabolic control of radiotherapy$419,461
R01 · FY2024 · CA · contact PI
Overcoming Tumor-Intrinsic Therapeutic Resistance to Immunotherapies$204,106
R21 · FY2023 · CA · contact PI
Overcoming Tumor-Intrinsic Therapeutic Resistance to Immunotherapies$173,559
R21 · FY2022 · CA · contact PI
Targeting metabolic checkpoints in the tumor microenvironment to boost efficacy of anti-CTLA-4$161,494
R21 · FY2020 · CA · contact PI
Targeting metabolic checkpoints in the tumor microenvironment to boost efficacy of anti-CTLA-4$193,793
R21 · FY2019 · CA · contact PI